Cristina Suárez

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

María Chaparro, A Garre, Marisa Iborra et al. · Journal of Crohn s and Colitis · 2021 · 81 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

Henit Yanai, A Kagramanova, O. V. Knyazev et al. · Journal of Crohn s and Colitis · 2022 · 63 citations · Full text

Medicine, Clinical Sciences, Surgery +15

Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease

Iago Rodríguez–Lago, Javier del Hoyo, Alexandre Pérez‐Girbés et al. · United European Gastroenterology Journal · 2020 · 47 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

Paul Bastard, Adrian Gervais, Maki Taniguchi et al. · The Journal of Experimental Medicine · 2024 · 39 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11